Spotfire for Life Sciences

The scientific community now understands disease biology better than ever before and has the tools to make a difference in how novel medicines are developed that can save lives. Yet, every new drug launch is a heroic effort. With new emphasis on reforming the global healthcare system, this situation will not be allowed to continue much longer.

Announcing TIBCO Spotfire Clinical - New Solution Integrates with Leading Clinical Development Systems

Genomics InstituteThe events leading up to gaining approval to market a new drug and the process of monitoring the long-term behavior of the drug in the human system are at the core of life science organizations. Simplifying human-data interaction is the key to better decisions across the drug discovery and development process. TIBCO Spotfire is the new platform for a high performance drug development organization.

From early stage discovery to clinical development to marketing and sales force optimization, Spotfire helps the world’s leading pharmaceutical, medical device, and biotech companies discover new therapeutics, develop their pipeline of assets, launch their drugs to the market, and align marketing and sales campaigns to maximize return on their enterprise information investments.

Life Sciences


Target and Biomarker Discovery: 

Lead Discovery and Optimization:

Clinical Development:

Sales and Marketing Analytics:

Related Demos

  • Enables rapid clinical data quality assessment, data cleaning deliverables to be met, provides visibility across programs, projects and studies; as well as optimal project and staff management
  • Provides a dashboard view that consolidates and presents all clinical supply-related data in one location of investigational product supply and distribution operations to measure the health of the organization’s internal and external supply chain operations.
  • An interactive analysis enabling you to define a set of gene clusters and evaluate their expression profiles.
  • HCS Tox Assay - Notes This High content Screening (HCS) assay is part of a predicitive toxicology screen, carried out to identify problem compounds in advance of animal or clinical studies. Cells were grown in 96 well plates, treated with test compound, labelled with two different dyes: one which labels nuclei and gives information on cell counts and cell health, the other is an indicator of a secondary toxic effect, which accumulates in specific sub-cellular organelles. Not all compounds casue the secondary effect. Data comes from two sources - individual cell stats (1 datapoint per cell) and pre-aggregated stats per well. There is also a template file giving details of the concetrations and location of test and control compounds.
  • An application which uses public data to evaluate the research pipelines of the top 20 pharmaceutical companies.
Print Page Send Page Add to Favorites Content Center
Spotfire Newsletters

Spotfire's interactive information visualization and analytic solutions give users a remarkable experience for quickly and easily querying data and reporting results for superior business intelligence. From portfolio management and customer retention programs to key processes such as CRM, marketing, research, bioinformatics, yield and asset management and design for manufacturing, enterprises around the world rely on Spotfire's business analytics software to improve operational performance.

©Copyright 2000-2011 TIBCO Software Inc | Privacy Policy | Terms of Use I Blog I Contact Us I Content Center